Analogues

Dibazol ‑Darnitsa, PapazolDarnitsa, PapazolLHFZ, Papazol, Andipal , Andipal ‑neo , Andipal ‑forte, Andipal ‑extra.

pharmachologic effect

It has a vasodilating, antispasmodic and hypotensive effect, as well as a stimulating effect on the functions of the spinal cord, and helps to restore the functions of peripheral nerves. Possesses moderately expressed immunostimulating activity.

Indications for use

AH, hypertensive crisis, spasms of blood vessels and smooth muscles of internal organs, diseases of the nervous system.

Dosage and administration

Assign in / in, in / m or inside. To stop a hypertensive crisis, 3–4 ml of 1% rra is administered intravenously or ‑intramuscularly up to 3–4 times a day. In severe hypertension, intramuscular administration of 2–3 ml of 1% r ‑ra 2–3 times a day is indicated, the course of treatment is 8–14 days.

Inside appoint 0.02-0.05 g 2-3 times a day for 3-4 weeks. In the treatment of patients with diseases of the nervous system, adults are prescribed orally at a dose of 0.005 g 1 time per day or every other day for a course of 5-10 days. After 3-4 weeks, the treatment is repeated.

Side effects

Usually well tolerated.

Contraindications

Hypersensitivity to the drug.

Diseases that occur with a decrease in muscle tone, convulsive syndrome. Severe heart failure. Arterial hypotension. Chronic nephritis with edema and impaired nitrogen excretion of the kidneys.

An ulcer of the stomach and duodenum, accompanied by bleeding. Diabetes.

Overdose

There is no data.